Cargando…
Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems
Delivery of most drugs into the central nervous system (CNS) is restricted by the blood–brain barrier (BBB), which remains a significant bottleneck for development of novel CNS-targeted therapeutics or molecular tracers for neuroimaging. Consistent failure to reliably predict drug efficiency based o...
Autores principales: | Neumaier, Felix, Zlatopolskiy, Boris D., Neumaier, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538549/ https://www.ncbi.nlm.nih.gov/pubmed/34683835 http://dx.doi.org/10.3390/pharmaceutics13101542 |
Ejemplares similares
-
Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics
por: Neumaier, Felix, et al.
Publicado: (2020) -
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
por: Neumaier, Felix, et al.
Publicado: (2023) -
Preparation of N(In)-Methyl-6-[(18)F]fluoro- and 5-Hydroxy-7-[(18)F]fluorotryptophans as Candidate PET-Tracers for Pathway-Specific Visualization of Tryptophan Metabolism
por: Kolks, Niklas, et al.
Publicado: (2023) -
Preparation of a First (18)F-Labeled Agonist for M(1) Muscarinic Acetylcholine Receptors
por: Zlatopolskiy, Boris D., et al.
Publicado: (2020) -
Current Concepts in Penetrating and Blast Injury to the Central Nervous System
por: Rosenfeld, Jeffrey V., et al.
Publicado: (2014)